Heart Test Laboratories
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 15
- Market Cap
- -
- Introduction
Heart Test Laboratories, Inc. is a medical technology company, which focuses on applying innovative AI-based technology to an electrocardiogram (ECG) to expand and improve an ECG's clinical usefulness. Its objective is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It offers MyoVista, a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction. The company was founded in 2008 and is headquartered in Southlake, TX.
HeartSciences Advances AI-ECG Technology for Early Heart Disease Detection
• HeartSciences is developing cloud and device-based AI-ECG solutions for versatile heart disease detection across healthcare settings.
• The MyoVista Insights Platform, featuring an LVEF algorithm licensed from Mount Sinai, targets FDA submission in the second half of 2025.
• FDA 510(k) submission for the MyoVista® wavECG™ device remains on track for the first calendar quarter of 2025.
• Recent patents granted for detection of ventricular dysfunction using deep learning and MyoVista Wavelet Technology expand HeartSciences' IP.
© Copyright 2025. All Rights Reserved by MedPath